Preferences of adults with cancer for systemic cancer treatment: do preferences differ based on age?

Author:

Dhakal Prajwal1ORCID,Wichman Christopher S2,Pozehl Bunny3,Weaver Meaghann45,Fisher Alfred L6,Vose Julie78,Bociek R Gregory78,Bhatt Vijaya R78ORCID

Affiliation:

1. Department of Internal Medicine, Division of Hematology, Oncology, and Blood & Marrow Transplantation, University of Iowa Health Care, Iowa City, IA 52242, USA

2. Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE 68198,USA

3. College of Nursing - Omaha Division, University of Nebraska Medical Center, Omaha, NE 68198, USA

4. Division of Pediatric Palliative Care, Children's Hospital & Medical Center, Omaha, NE 68114, USA

5. Department of Pediatrics, Division of Pediatric Hematology/Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA

6. Division of Geriatrics, Gerontology and Palliative Medicine, University of Nebraska Medical Center, Omaha, NE 68198, USA

7. Department of Internal Medicine, Division of Hematology–Oncology, University of Nebraska Medical Center, Omaha, NE 68198, USA

8. Fred and Pamela Buffett Cancer Center, University of Nebraska Medical Center, Omaha, NE 68198, USA

Abstract

Background: We used the Therapy Preference Scale, a 30-item questionnaire, to determine cancer treatment preferences of adults with cancer. Methods: We used Wilcoxon’s rank sum test and Fisher’s exact test to compare the preferences of younger (<60 years) versus older adults (≥60 years). Results: While 56% of patients would accept treatment offering increased life expectancy at an expense of short-term side effects, 75% preferred maintenance of cognition, functional ability and quality of life to quantity of days. Oral instead of intravenous treatment (p = 0.003), shorter hospital stay (p = 0.03), preservation of cognitive function (p = 0.01) and avoidance of pain (p = 0.02) were more important to older patients compared with younger patients. Conclusion: Many patients prioritized maintenance of cognition, functional ability and quality of life; older patients valued oral treatment, shorter hospital stay, preservation of cognitive function and avoidance of pain.

Funder

National Institute of General Medical Sciences

Publisher

Future Medicine Ltd

Subject

Cancer Research,Oncology,General Medicine

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3